SAVIENT PHARMACEUTICALS INC: cashflow_investing
| Value | {"amount": -20303000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2010-01-01 – 2010-12-31 |
| Status | current |
| Entity | SAVIENT PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:42:09.071666+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/caa09ab2-84dc-48ff-8102-660a40a9bf78
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-089563 · Open the official SEC filing →Retrieved: 2026-08-19T07:42:09.071666+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000722104/cashflow-investing/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/caa09ab2-84dc-48ff-8102-660a40a9bf78
History
- supersedes {"amount": -20292000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001193125-11-051607)